Summary
Bone density (BD) at the distal end of the radius was measured serially with gamma-ray computed tomography (γ-CT) in five groups of healthy postmenopausal women. One group comprised untreated controls; women in the other groups were subjected to pharmacologic challenge with putative activators and/or depressors of bone remodeling. The challenge agents, taken orally, were ergocalciferol (vitamin D2) alone and followed by calcium; calcitriol (1,25 OH)2D3), and prednisone. All of the subjects showed changes in BD following challenge; these changes were significant (P<0.05) for the groups receiving vitamin D2 and vitamin D2 plus calcium. Responses to ergocalciferol, calcitriol, and prednisone were similar within groups, whereas the group receiving ergocalciferol then calcium comprised two distinct subgroups: bone density transiently increased in one and decreased in the other. For all five groups, the direction of change in bone density in response to the challenge, and its duration and magnitude, were consistent with reported histomorphometric data. We conclude that γ-CT assessment of change in bone density after pharmacologic challenge provides a useful noninvasive approach to skeletal investigation.
Similar content being viewed by others
References
Frost HM (1964) Dynamics of bone remodeling. In: Frost HM (ed) Bone biodynamics. Little, Brown, Boston, pp 315–333
Frost HM (1979) Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop 143:227–244
Parfitt AM (1983) The physiologic and clinical significance of bone histomorphometric data In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, Florida, pp 143–223
Recker RR (1980) Stimulation of new bone formation by the “ADFR” technique in dogs. Metab Bone Dis Relat Res 2S:331–336
Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 12:629–648, 661
Rüegsegger P, Elsasser U, Anliker M, Gnehm H, Kind H, Prader A (1976) Quantification of bone mineralization using computed tomography. Radiology 121:93–97
Hangartner TN, Overton TR (1982) Quantitative measurement of bone density using gamma-ray computed tomography. J Comput Assist Tomogr 6:1156–1162
Haddad JG, Chyu KJ (1971) Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:992–995
von Westarp C, Outhet D, Eaton RDP (1982) Prevalence of vitamin deficiency in two Canadian arctic communities. In: Harvald B, Hansen JP (eds) circumpolar Health 81, 33: 331–333
Commbes RC, Hillyard C, Greenberg PB MacIntyre I (1974) Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet 1080–1083
Hehrmann R, Nordmeyer JP, Wilke R, Hesch RD (1977) Radioimmunoassay of human PTH: characterization of two new antisera from sheep and clinical results. Acta Endocrinol Suppl 208:117–118
Meunier PJ, Courpron, P, Edouard C, Alexandre C, Bressot C, Lips P, Boyce BF (1979) Bone histomorphometry in osteoporotic states. In: Barzel US (ed) Osteoporosis II. Grune & Stratton, New York, pp 27–47
Avioli LV, Baran DT, Whyte MP, Teitelbaum SL (1979) The biochemical and skeletal heterogeneity of “post-menopausal osteoporosis”. In: Barzel US (ed) Osteoporosis II. Grune & Stratton, New York, pp 49–64
Jett S, Wu K, Duncan H, Frost HM (1970) Adrenal corticosteroid and salicylate actions on human and canine haversian bone formation and resorption. Clin Orthop 68:301–315
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hangartner, T.N., Overton, T.R., Harley, C.H. et al. Skeletal challenge: An experimental study of pharmacologically induced changes in bone density in the distal radius, using gamma-ray computed tomography. Calcif Tissue Int 37, 19–24 (1985). https://doi.org/10.1007/BF02557673
Issue Date:
DOI: https://doi.org/10.1007/BF02557673